Novel Fused Pyrimidines as Potent Cyclin-Dependent Kinases Inhibitor for Gastric Adenocarcinoma: Combined In&#160;Vitro, In Silico Anticancer Studies.

seliciclib (CYC202) - Cyclacel, Cedars-Sinai

http://www.ncbi.nlm.nih.gov/pubmed/39543948

Anantha Krishnan Dhanabalan; Arunagiri Sivanesan Aruna Poorani; Ganesan Kumaresan; Natarajan Saravanakumar; Palaniswamy Suresh; Selvam Sugapriya

Nov 17, 2024